With ever-growing treatment options, clinical care access and a new focus on integrative strategies, cancer centers are constantly upgrading their services and options for patients. Becker’s asked ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Modulating the gut microbiome may improve immunotherapy outcomes in solid tumors including melanoma, RCC, and NSCLC, offering ...

Researchers in China say the bacteria in your gut—and beyond—may play a role in your chance of developing one of the leading ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

A 2024 systematic review found that immune checkpoint inhibitors, a type of immunotherapy, were usually more cost-effective than chemotherapy treatment options for advanced non-small cell lung cancer.

Patients using steroids, especially at high-doses, before taking immune checkpoint inhibitors for non–small cell lung cancer ...

These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...

OST-HER2 already holds several valuable FDA designations, including Orphan Drug, Fast Track, and Rare Pediatric Disease. If the therapy is approved before September 30, 2026, OSTX will be eligible to ...

Jazz Pharmaceuticals (JAZZ) stock gains as its lung cancer therapy Zepzelca, in combination with Roche's Tecentriq, receives FDA priority review. Read more here.

A grandad with advanced lung cancer which often leaves patients dead within four months has become free of the disease after being treated with a new immunotherapy drug. Jeff Cook, 76, was told he ...